Abits
ABTS
Bit Origin
BTOG
Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
PTGX Protagonist Therapeutics
- 38.530
- +0.020+0.05%
Trading Dec 31 12:06 ET
2.30BMarket Cap14.06P/E (TTM)
39.860High38.130Low87.80KVolume39.000Open38.510Pre Close3.39MTurnover0.18%Turnover RatioLossP/E (Static)59.60MShares48.89052wk High4.32P/B1.84BFloat Cap21.71052wk Low--Dividend TTM47.67MShs Float50.540Historical High--Div YieldTTM4.49%Amplitude4.470Historical Low38.618Avg Price1Lot Size
Protagonist Therapeutics Key Stats
EPS
According to the latest financial report of Protagonist Therapeutics, the latest earnings per share (TTM) for the company is -0.54. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Protagonist Therapeutics's free cash flow? The latest report shows it as -28.64M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Protagonist Therapeutics shows that the company's current ratio is 10.70, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Protagonist Therapeutics, the quick ratio is 10.57, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Protagonist Therapeutics? The latest ROE figure is -6.19%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Protagonist Therapeutics, the total asset return on investment (ROA) is -5.45%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Protagonist Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Protagonist Therapeutics, the net profit margin is -710.37%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.